...
首页> 外文期刊>Pathology oncology research: POR >Meta-Analysis of Oncological Outcome After Abdominoperineal Resection or Low Anterior Resection for Lower Rectal Cancer
【24h】

Meta-Analysis of Oncological Outcome After Abdominoperineal Resection or Low Anterior Resection for Lower Rectal Cancer

机译:下直肠癌腹部手术切除或低位前切除术后肿瘤结局的Meta分析

获取原文
           

摘要

id="Par1" class="Para">In lower rectal cancer, postoperative outcome is still subject of controversy between the advocates of abdominoperineal resection (APR) and low anterior resection (LAR). Reports suggest that low anterior resection may be oncologically superior to abdominoperineal excision, although no good evidence exists to support this. Publications were identified which assessed the differences comparing 5-year survival, local recurrence, circumferential resection margin rate, complications and so on. A meta-analysis was performed to clarify the safety and feasibility of the two procedures with several types of outcome measures. A total of 13 studies met the inclusion criteria, and comprised 6,850 cases. Analysis of these data showed that LAR group was highly correlated with 5-year survival (pooled ORa€‰=a€‰1.73, 95%CI: 1.30-2.29, Pa€‰=a€‰0.0002 random-effect). And local recurrence rate of APR group was significantly higher than that in LAR group (pooled ORa€‰=a€‰0.63, 95%CI: 0.53-0.75, Pa€‰a€‰0.00001 fixed-effect). Also, the circumferential resection margin (CRM) were high involved in APR group than in LAR group. (5 trials reported the data, pooled ORa€‰=a€‰0.43, 95%CI: 0.36-0.52, Pa€‰a€‰0.00001 fixed-effect). Besides, the incidents of overall complications of APR group was higher compared with LAR group (pooled ORa€‰=a€‰0.52, 95%CI: 0.29-0.92, Pa€‰=a€‰0.03 random-effect). Patients treated by APR have a higher rate of CRM involvement, a higher local recurrence, and poorer prognosis than LAR. And there is evidence that in selected low rectal cancer patients, LAR can be used safely with a better oncological outcome than APR. due to the inherent limitations of the present study, for example, the trails available for this systematic review are limited and the finite retrospective data, future prospective randomized controlled trials will be useful to fully investigate these outcome measures and to confirm this conclusion.
机译:id =“ Par1” class =“ Para”>在下直肠癌中,腹部手术切除(APR)和低位前切除(LAR)的提倡者之间仍存在争议。报告表明,尽管在肿瘤学上尚无很好的证据支持,但低位前切除术在肿瘤学上可能优于腹部手术切除。鉴定出的出版物评估了比较5年生存率,局部复发,环周切除切缘率,并发症等方面的差异。进行了荟萃分析,以阐明两种程序的安全性和可行性,并采用几种类型的结果指标。共有13项研究符合纳入标准,包括6,850例。对这些数据的分析表明,LAR组与5年生存率高度相关(合计 OR a = 1.73,95%CI:1.30-2.29, P a = 0.0002随机效果)。 APR组的局部复发率显着高于LAR组(合并 OR a = 0.63,95%CI:0.53-0.75, P a€ OR a = 0.43,95%CI:0.36-0.52, P a <0.00001固定效果)。此外,与LAR组相比,APR组的总体并发症发生率更高(合并 OR a = 0.52,95%CI:0.29-0.92, P a = 0.03随机效果)。与LAR相比,接受APR治疗的患者具有更高的CRM参与率,更高的局部复发率和更差的预后。并且有证据表明,在某些低位直肠癌患者中,LAR可比APR更好地安全使用,并具有更好的肿瘤学结局。由于本研究的固有局限性,例如,可用于本系统评价的线索有限且回顾性数据有限,未来的前瞻性随机对照试验将有助于全面研究这些结果指标并确认该结论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号